Quarterly Results • Search Archive

Concord Biotech Limited
Results, Financials & Updates

Follow Concord Biotech Limited results and financial updates in one company page: latest revenue or income, profit, margins, quarter comparisons, what changed and detailed Nivata Results deep dives.

1 published deep dive 1 quarter 1 sector

Company Overview

Concord Biotech Limited: latest results and financials

Latest covered quarterQ2 FY27NSE: CONCORDBIO
Revenue from operations₹309.07 CrReported in the latest covered quarter
Profit after tax₹69.57 CrReported in the latest covered quarter
Margin—Latest available reported margin
About the business in Nivata's latest coverage

Concord Biotech Limited operates as a biopharmaceutical company specializing in the development and manufacturing of complex fermentation-based active pharmaceutical ingredients (APIs) and finished formulations. The company serves global pharmaceutical markets, supplying its specialized portfolio across multiple regulated geographies through advanced manufacturing facilities.

← All quarterly results

Quarter history

Concord Biotech Limited Results & Financials

Latest Nivata coverage: Q2 FY27 · revenue ₹309.07 Cr · PAT ₹69.57 Cr.

Nivata currently has one covered quarter for this company. This page remains the stable company-results hub and expands automatically as additional quarters are published.